When to start and stop hepatitis B treatment: Can one set of criteria apply to all patients regardless of age at infection?

被引:9
作者
Degertekin, Bulent [1 ]
Lok, Anna S. F. [1 ]
机构
[1] Univ Michigan Hlth Syst, Div Gastroenterol, Ann Arbor, MI 48109 USA
关键词
D O I
10.7326/0003-4819-147-1-200707030-00011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:62 / 64
页数:3
相关论文
共 19 条
[1]  
CARMAN WF, 1989, LANCET, V2, P588
[2]  
Chang TT, 2006, HEPATOLOGY, V44, p229A
[3]   Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection [J].
Chu, CJ ;
Hussain, M ;
Lok, ASF .
HEPATOLOGY, 2002, 36 (06) :1408-1415
[4]   Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels [J].
Chu, CM ;
Hung, SJ ;
Lin, J ;
Tai, DI ;
Liaw, YF .
AMERICAN JOURNAL OF MEDICINE, 2004, 116 (12) :829-834
[5]   EASL International Concensus Conference on Hepatitis B -: 13-14 September, 2002 Geneva, Switzerland Consensus Statement (Long version) [J].
de Franchis, R ;
Hadengue, A ;
Lau, G ;
Lavanchy, D ;
Lok, A ;
McIntyre, N ;
Mele, A ;
Paumgartner, G ;
Pietrangelo, A ;
Rodés, J ;
Rosenberg, W ;
Valla, D .
JOURNAL OF HEPATOLOGY, 2003, 39 :S3-S25
[6]   Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B [J].
Hadziyannis, SJ ;
Tassopoulos, NC ;
Heathcote, EJ ;
Chang, TT ;
Kitis, G ;
Rizzetto, M ;
Marcellin, P ;
Lim, SG ;
Goodman, Z ;
Ma, J ;
Arterburn, S ;
Xiong, S ;
Currie, G ;
Brosgart, CL .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26) :2673-2681
[7]   Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years [J].
Hadziyannis, Stephanos J. ;
Tassopoulos, Nicolaos C. ;
Heathcote, E. Jenny ;
Chang, Ting-Tsung ;
Kitis, George ;
Rizzetto, Mario ;
Marcellin, Patrick ;
Lik, Seng Gee ;
Goodman, Zachary ;
Ma, Jia ;
Brosgart, Carol L. ;
Eorroto-Esoda, Katyna ;
Arterburn, Sarah ;
Chuck, Steven L. .
GASTROENTEROLOGY, 2006, 131 (06) :1743-1751
[8]   Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B [J].
Hsu, YS ;
Chien, RN ;
Yeh, CT ;
Sheen, IS ;
Chiou, HY ;
Chu, CM ;
Liaw, YF .
HEPATOLOGY, 2002, 35 (06) :1522-1527
[9]   Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study [J].
Kim, HC ;
Nam, CM ;
Jee, SH ;
Han, KH ;
Oh, DK ;
Suh, I .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7446) :983-986C
[10]   The natural history and evaluation of standard treatment of chronic hepatitis B: A critical treatment criteria and end points [J].
Lai, Ching-Lung ;
Yuen, Man-Fung .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (01) :58-61